228. 閉塞性細気管支炎 Bronchiolitis obliterans Clinical trials / Disease details

臨床試験数 : 96 / 薬物数 : 125 - (DrugBank : 34) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 155

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01307462 (ClinicalTrials.gov)	June 2011	1/3/2011	Targeted Therapy of Bronchiolitis Obliterans Syndrome	Fluticasone Propionate, Azithromycin, and Montelukast Sodiumin Treating Patients With Bronchiolitis ...	Bronchiolitis Obliterans	Drug: fluticasone propionate;Drug: montelukast sodium;Drug: azithromycin	Stephanie Lee	National Cancer Institute (NCI)	Completed	6 Years	99 Years	All	36	Phase 2	United States
2	EUCTR2010-021983-14-BE (EUCTR)	23/09/2010	02/09/2010	A randomized placebo-controlled double blind study to treat BOS.	A randomized placebo-controlled double blind study to treat BOS.	-Mortality at 1 and 2 year post diagnosis of BOS-Infection rate during BOS-Evolution of pulmonary fu ...	Trade Name: Montelukast Teva Product Name: montelukast teva Product Code: NA INN or Proposed INN: MONTELU ...	UZ Gasthuisberg	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30		Belgium
3	NCT00656058 (ClinicalTrials.gov)	June 17, 2008	9/4/2008	Montelukast to Treat Bronchiolitis Obliterans	Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obl ...	Bronchiolitis Obliterans;Chronic Graft Versus Host Disease;Leukotriene;Montelukast;Stem Cell Transpl ...	Drug: Singulair (Montelukast Sodium)	National Cancer Institute (NCI)	NULL	Completed	6 Years	80 Years	All	25	Phase 2	United States

First Previous1Next Last